ARAGNO, Manuela
 Distribuzione geografica
Continente #
NA - Nord America 11.243
EU - Europa 6.330
AS - Asia 4.538
SA - Sud America 139
AF - Africa 92
OC - Oceania 71
Continente sconosciuto - Info sul continente non disponibili 25
Totale 22.438
Nazione #
US - Stati Uniti d'America 11.015
CN - Cina 2.504
IT - Italia 1.440
SE - Svezia 801
IE - Irlanda 743
SG - Singapore 689
DE - Germania 515
UA - Ucraina 472
DK - Danimarca 420
FR - Francia 419
FI - Finlandia 386
GB - Regno Unito 379
KR - Corea 310
VN - Vietnam 199
PL - Polonia 194
JP - Giappone 186
CA - Canada 161
TR - Turchia 101
AT - Austria 98
ID - Indonesia 98
IN - India 95
ES - Italia 84
BE - Belgio 81
HK - Hong Kong 79
TW - Taiwan 74
BR - Brasile 72
MX - Messico 64
AU - Australia 56
NL - Olanda 52
GR - Grecia 49
RU - Federazione Russa 44
EG - Egitto 32
RO - Romania 32
IR - Iran 30
SN - Senegal 30
TH - Thailandia 30
PH - Filippine 26
CH - Svizzera 24
PK - Pakistan 24
EU - Europa 23
CZ - Repubblica Ceca 21
NO - Norvegia 21
AR - Argentina 19
CL - Cile 19
IL - Israele 18
HU - Ungheria 16
NZ - Nuova Zelanda 15
SA - Arabia Saudita 15
MY - Malesia 14
CO - Colombia 12
DZ - Algeria 10
PE - Perù 10
UZ - Uzbekistan 9
BD - Bangladesh 7
BG - Bulgaria 7
RS - Serbia 7
IQ - Iraq 6
PT - Portogallo 6
MO - Macao, regione amministrativa speciale della Cina 5
ZA - Sudafrica 5
HR - Croazia 4
KW - Kuwait 4
KZ - Kazakistan 4
MU - Mauritius 4
NG - Nigeria 4
AE - Emirati Arabi Uniti 3
LT - Lituania 3
LU - Lussemburgo 3
A1 - Anonimo 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BT - Bhutan 2
EC - Ecuador 2
HN - Honduras 2
KH - Cambogia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
BF - Burkina Faso 1
BJ - Benin 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
IS - Islanda 1
KE - Kenya 1
LI - Liechtenstein 1
MD - Moldavia 1
PR - Porto Rico 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
UY - Uruguay 1
Totale 22.438
Città #
Ann Arbor 1.980
Beijing 1.260
Chandler 1.165
Dublin 728
Houston 556
Singapore 552
Fairfield 489
Torino 475
Santa Clara 459
Ashburn 369
Wilmington 367
Jacksonville 336
Dearborn 287
Woodbridge 275
Villeurbanne 255
Nyköping 249
Medford 223
Princeton 217
Redwood City 208
Seattle 205
Columbus 184
Cambridge 179
Warsaw 178
Pisa 151
Dong Ket 136
Turin 125
Shanghai 109
Guangzhou 102
Boardman 91
Jakarta 89
Milan 86
Vienna 86
Nanjing 83
Boston 76
Frankfurt am Main 71
Fremont 64
Brussels 60
Menlo Park 60
Toronto 59
New York 50
Helsinki 47
Zhengzhou 45
Wuhan 42
Taipei 41
Verona 39
Hefei 37
Rome 37
Xian 36
San Diego 35
Tokyo 35
Hangzhou 34
Ottawa 34
Chengdu 32
London 32
Shenyang 32
Washington 31
Norwalk 28
Düsseldorf 27
Hong Kong 27
Los Angeles 27
Seoul 25
Phoenix 24
Chongqing 23
Hebei 23
Kunming 23
Athens 22
Jinan 22
Ankara 21
Central 21
Changsha 21
Lappeenranta 20
Lachine 19
Silver Spring 19
Chicago 17
Madrid 17
Falls Church 16
Nuremberg 16
San Mateo 16
Istanbul 15
Munich 15
Tianjin 14
Harbin 13
Santiago 13
Nanchang 12
Oslo 12
Detroit 11
Fuzhou 10
Guiyang 10
Mountain View 10
Pune 10
San Jose 10
College Station 9
Delhi 9
São Paulo 9
Tappahannock 9
Vancouver 9
Buffalo 8
Central District 8
Mexico 8
Novara 8
Totale 13.989
Nome #
Metaflammation: tissue-specific alterations of the NLRP3 inflammasome platform 1.265
Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. 684
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by alpha Ketoglutarate and TET-TDG Functional Reactivation 463
AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation 429
Effects of high fat diets and Spirulina Platensis supplementation in New Zealand White rabbit 407
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study 335
Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways 323
Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice 314
Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR- agonism correlates with impaired NLRP3 inflammasome activation 299
Dysregulation of SREBP2 induces BACE1 expression. 294
Effect of hyperglycaemia and diabetes on acute myocardial ischaemia–reperfusion injury and cardioprotection by ischaemic conditioning protocols 290
A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice 289
Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle. 281
Is NLRP3 inflammasome a new pharmacological target in myocardial ischemia/reperfusion injury? 279
Advanced glycation end-products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose drinking mice 269
Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice 250
Alpha-2A Adrenoceptor Agonist Guanfacine Restores Diuretic Efficiency in Experimental Cirrhotic Ascites: Comparison with Clonidine 246
Dietary sugars and endogenous formation of advanced glycation endproducts: Emerging mechanisms of disease 245
Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data 232
SALIVAGE – EU JPI Project The “form” makes the difference: comprehensive two‐dimensional gas chromatography as highly informative fingerprinting tool to study the impact of fructose formulation on mice’s microbiota and its volatile metabolome signatures 232
High Sugar Intake and Development of Skeletal Muscle Insulin Resistance and Inflammation in Mice: A Protective Role for PPAR- δ Agonism. 230
Exacerbation of myocardial ischemia/reperfusion injury induced by high-fat-high-fructose (HFHF) diet: Role of NLRP3 inflammasome 223
Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats. 216
Variability in myosteatosis and insulin resistance induced by high-fat diet in mouse skeletal muscles. 214
Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver 205
Cardiac impairment in rabbits fed a high-fat diet is counteracted by dehydroepiandrosterone supplementation 203
Effects of chronic sugar consumption on lipid accumulation and autophagy in the skeletal muscle 195
Fructose-derived advanced glycation end-products induce a negative crosstalk between lipogenesis and muscle reprogramming in mice through SREBP-1c 194
Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts 191
Advanced Glycation End Products Inhibition Restores Sphingolipid Rheostat in Mice Liver and Prevents Diet-Induced Insulin Resistance 188
Pyridoxamine prevents diet-induced insulin resistance through the regulation of ceramide/sphingosine/sphingosine-1-phosphate equilibrium in mice liver 186
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice 184
High-fructose intake as risk factor for neurodegeneration: Key role for carboxy methyllysine accumulation in mice hippocampal neurons 178
Study of the photocatalytic transformation of synephrine: a biogenic amine relevant in anti-doping analysis 176
Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643 174
A LIPIDOMIC STUDY OF HIGH-FAT DIET TREATED MICE. 173
Role of temperature in myocardial ischemic injury and protection by conditioning 173
Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. 165
Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: attenuation by dehydroepiandrosterone. 165
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 164
A nonerythropoietic peptide analog of erythropoietin decreases susceptibility to diet-induced insulin resistance 156
Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation 155
Fructose-Derived Advanced Glycation End-Products Evoke Skeletal Muscle Damage in Mice by Multiple Interference with SCAP-SREBP Pathway 154
Effects of Vitamin D on insulin resistance and myosteatosis in diet-induced obese mice 153
Calcium receptors located in fibrotic septa: a new target to reduce portal pressure in liver cirrhosis 151
Identification of Annexina1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes 151
Advanced glycation end products (AGEs) as pathology biomarkers: microwave assisted synthesis and biological quantitative analysis by LC-FTMS 148
Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: A possible role in the onset of late complications 147
Multiple courses of G-CSF in patients with decompensated cirrosi: consistent mobilization of immature cells ex pressing hepatocyte markers and exploratory clinical evaluation. 144
4-Idrossinonenale come stimolo pro-fibrogenico selettivo per le cellule stellate umane attivate 138
Ischaemic preconditioning modulates the activity of Kupffer cells during in vivo reperfusion injury of rat liver 137
Inhibition of chymase-dependent production of kidney angiotensin II improves renal sodium handling and prevents ascites in experimental liver cirrhosis 135
Toxicological impact of high fructose intake on gut microbiota and liver/intestine integrity: Any differences between solid and liquid formulations? 132
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction 131
Dynamics of sodium retention in preascitic cirrhotic rats assessed through parathyroid hormone injection. 131
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice 131
The AGEs inhibitor pyridoxamine prevents kidney injury and dysfunction in mice fed high-fat high-fructose diet 129
Dose-dependecy of clonidine's effects in ascitic cirrhotic rats: Comparison with α1-adrenergic agonist midodrine. 128
Pathogenesis of Solute-Free Water Retention in Experimental Ascitic Cirrhosis: Is Vasopressin the Only Culprit? 128
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells 126
Inflammatory signaling and insulin resistance caused by sugar intake: modulation by PPAR-δ agonism 124
Dehydroepiandrosterone pretreatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride. 123
Acetaldehyde involvement in ethanol-induced potentiation of rat hepatocyte damage due to the carcinogen 1,2-dibromoethane. 119
Ischemic preconditioning attenuates the oxidant-dependent mechanisms of reperfusion cell damage and death in rat liver. 114
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation 114
Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation 113
Dehydroepiandrosterone inhibits the growth of DMBA-induced rat mammary carcinoma via the androgen receptor. 107
A model for monitoring changes in liver function. 107
Oxygen free radical scavenger properties of dehydroepiandrosterone. 105
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades 105
AGEs up-regulates BACE1 through their interaction with RAGE and NFkB activation. 103
Change of liver metabolism of 1,2-dibromoethane during simultaneous treatment with carbon tetrachloride. 102
Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. 101
AGEs induce alterations of sphingolipids metabolism in the liver of genetically- and diet-induced diabetic mice 101
Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. 99
Liver AP-1 activation due to carbon tetrachloride is potentiated by 1,2-dibromoethane but is inhibited by alpha-tocopherol or gadolinium chloride. 98
Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose 96
Dietary advanced glycation endproducts in the mechanisms linking proteins glycosylation pattern, microbiota, and metabolic inflammation 96
Advanced Glycation End-Products Promote Lipogenesis in Liver of Fructose-Drinking Mice 95
Do P2Y12 receptor antagonism and NLRP3 inhibition exert additive cardioprotective effects against ischemia/reperfusion injury? 95
Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems 94
[Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa] 93
Baricitinib counteracts metaflammation protecting against diet-induced metabolic abnormalities in mice 93
In experimental ascitic cirrhosis reduction of adrenergic function by means of α2A adrenergic receptor agonists has considerable aquaretic effects 92
Experimental studies on the toxicity of Ferula communis in the rat. 91
Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients 91
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy 90
Considerable aquaretic effects in experimental ascitic cirrhosis achieved through blunting of adrenergic function with α2A adrenergic receptor agonists 89
NT2 neurons, a classical model for Alzheimer's disease, are highly susceptible to oxidative stress 88
Local renin–angiotensin system in the kidney of ascitic cirrhosis: An innocent bystander or a major protagonist? 88
Calcium-dependent diuretic system in preascitic liver cirrhosis. 87
Ethanol-induced potentiation of rat hepatocyte damage due to 1,2-dibromoethane. 86
Experimental studies on the toxicity of some compounds isolated from Ferula communis in the rat. 85
In vivo potentiation of 1,2-dibromoethane hepatotoxicity by ethanol through inactivation of glutathione-s-transferase. 85
Pathway of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver disease 84
In vivo studies on halogen compound interactions. III. Effect of carbon tetrachloride plus 1,2-dichloroethane on liver necrosis and fatty accumulation. 83
In vivo studies on halogen compound interactions. II. Effects of carbon tetrachloride plus 1,2-dibromoethane on relative liver weight and hepatic steatosis. 82
Lipid peroxidation and irreversible cell damage: synergism between carbon tetrachloride and 1,2-dibromoethane in isolated rat hepatocytes. 81
Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats. 81
Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis 80
Totale 17.888
Categoria #
all - tutte 64.959
article - articoli 0
book - libri 0
conference - conferenze 19.357
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.535 0 0 0 0 0 0 321 186 337 276 215 200
2020/20213.012 213 139 221 195 312 227 235 155 343 293 171 508
2021/20223.743 318 271 269 336 290 230 332 300 187 181 486 543
2022/20233.647 396 278 122 382 334 856 263 231 416 88 175 106
2023/20241.689 218 279 106 95 133 202 77 98 20 113 150 198
2024/20252.055 48 255 210 416 843 279 4 0 0 0 0 0
Totale 23.184